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Progression of coronary artery stenosis was measured
using a quantitative, computer-assisted cinevideodensi-
tometric method in 144 arterial segments in 44 subjects
undergoing coronary arteriography on two separate oc-
casions at least 6 months apart. Projected coronary ar-
teriograms were digitized into 512 x 512 pixel mode
and percent stenosis was calculated by comparing back-
ground-corrected videodensitometric values over ste-
notic and normal segments. Subjects underwent repeat
coronary arteriography because of worsening symptoms
of angina or heart failure; subjects with renal failure,
coronary artery bypass grafts or cardiac transplant were
excluded. Clinical variables determined at the time of
the first arteriogram included age, sex, serum choles-
terol, systolic blood pressure and presence or absence
of cigarette smoking, diabetes mellitus and left ventric-
ular hypertrophy.
Progression of coronary artery atherosclerosis ultimately re-
sult s in worsening angina, myocardial infarction and death
(1-4) . Measurement and clinical investigation of progres-
sion of coronary disease have been limited in part by the
invasivene ss of coronary arteriography and in part by the
technical difficulty of obtaining accurate, quantitative mea-
surements of coronary artery stenoses demonstrated on coro-
nary arteriograms. Except for one recent study (5), in which
a computer-assisted edge detection algorithm was used , pre-
vious investigations (6-14) of progres sion ofcoronary artery
disease relied on visual or caliper assessment by panel s of
expert s to clas sify serial coronary arteriograms as exhibiting
or failing to exhibit progression . Howe ver, visual assess-
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The mean interval between arteriograms was 29.3
months. Overall progression of coronary stenosis was
observed in 40 of the 44 subjects; the mean progression
at 24 months was 39% (90% confidence interval, 33 to
45%)and at 36 months was 48% (40to 56%). The degree
of overall progression was related to the length of time
between arteriograms (F =5.81, p < 0.05) and to serum
cholesterol level (F = 4.37, P < 0.05).
These data indicate that using an accurate, quanti-
tative method, it is possible to measure progression of
coronary artery atherosclerosis within 2 to 3 years of the
initial arteriogram. Serum cholesterol appears to be an
important determinant of disease progression.
(J Am Coli CardioI1986;8:1325-31)
ment of coronary arteriograms lacks high intra- and inter-
observer reproducibility (15-18) and has only moderate cor-
relation with postmortem studies of arterial segments (19-21).
In addition, changes in coronary artery stenoses demon-
strated on serial arteriograms done over relatively short time
interval s are often small (10) and therefore difficult to mea-
sure reliably using conventional visual assessment method s.
Recently, a new cinevideodensitometric technique for
quantitati ve analysis of coronary arteriograms was devel-
oped and validated (22). Th is computer-assisted technique
measures percent stenosis based on digital analysis of the
radiopacity of the contrast mater ial within the lumen of each
arteri al segment. Selected cine frames are projected into a
vidicon camera, digitized into a 512 x 512 pixel matrix
with 256 gray levels and analyzed by comparing the back-
ground-corrected videodensitometric signal measured over
the stenotic segment to the background-corrected signal over
the normal arterial segment. The accuracy of this method
has been valid~ted in radiographic phantom studie s, in ex-
perimental studies of postmortem human hearts and in clin-
ical studies of interobserver variability (22). We used
cinevideodensitometric analy sis to study the relation be-
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tween the established coronary risk factors and progression
of coronary artery disease in 44 patients with angiograph-
ically documented disease.
Methods
Study patients. All adult patients who underwent repeat
coronary arteriography at an interval of greater than 6 months
in the cardiovascular laboratory of Presbyterian Hospital
between January I, 1976 and December 31, 1984 were
eligible for inclusion in the study. Patients were excluded
if they underwent coronary artery bypass graft surgery, coro-
nary artery transluminal angioplasty, cardiac transplantation
or chronic renal dialysis in the interval between the two
arteriograms.
Of the 54 patients with these entry criteria, 44 had ar-
teriograms of acceptable quality for cinevideodensitometric
analysis and complete clinical data. These 44 patients con-
stituted the study group. Thirty-five patients had coronary
artery disease and nine had valvular heart disease. In all
patients with the diagnosis of coronary artery disease, the
clinical indication for repeat arteriography was progressive
or intractable angina or recent myocardial infarction. In all
patients with valvular heart disease, the indication was wors-
ening congestive heart failure, and coronary arteriography
was performed to detect concomitant coronary artery disease
requiring coronary artery bypass grafting at the time of valve
replacement.
Clinical variables: coronary risk factors. From the
hospital record, the following seven coronary risk factors
were determined for each patient as of the date of the first
arteriogram: age, sex, serum cholesterol level, cigarette
smoking status, systolic blood pressure value. and presence
of diabetes and left ventricular hypertrophy on the rest elec-
trocardiogram. Serum cholesterol was recorded as the cho-
lesterol level measured on the day of or closest day to
cardiac catheterization. For a few patients who underwent
arteriography after a lengthy hospitalization during which
the serum cholesterol decreased significantly, the serum
cholesterol on the day of admission was recorded. Smoking
status at the time of first catheterization was recorded as
positive if the patient smoked any cigarettes. Pipe or cigar
smoking was not considered positive. Diabetes was consid-
ered to be present if the patient was under treatment for
diabetes with insulin, an oral hypoglycemic agent or a di-
abetic diet, if the patient was noted by the admitting phy-
sician to be diabetic or if a random glucose determination
at the time of admission was 200 mgldl or greater. Systolic
blood pressure was recorded as the first blood pressure re-
corded in the chart by a physician at the time of admission.
Left ventricular hypertrophy on the electrocardiogram was
scored by the Romhilt criteria (23).
On the basis of these seven risk factors. an aggregate
risk score was assigned to each patient using multivariate
criteria derived from the Framingham Heart Study (24,25).
This risk score predicts the likelihood that an asymptomatic
subject will develop symptomatic coronary heart disease
over the next 6 years.
All clinical variables were collected without knowledge
of each subject's degree and rate of progression of coronary
artery stenosis. The dates of the arteriograms were covered
on the cine film, so that percent stenosis of each lesion was
measured without knowledge of whether the arteriogram
was the earlier or later one. All stenoses were measured in
triplicate. and the mean value recorded; stenoses were also
measured without knowledge of any clinical data.
Coronary arteriography. Coronary cinearteriograms
were recorded on 35 mm cine film (Kodak CFR) at 32
framesls with an Arriftex camera. The radiographic equip-
ment consisted of a Philips modular generator, an SRN
10/80 X-ray tube and a trimodal (6,10,14 inch [15.2, 25.4,
35.6 cm]) cesium iodide image intensifier mounted on a
Poly Diagnost A arm and scanned with a Plumbicon vid-
eotube. The focal spot size for coronary cine ftuorography
was 0.7 mm. The image intensifier was operated in the 6
inch mode. and X-ray exposure time was 5 ms. Because of
the large size of the 14 inch image intensifier, the curvature
of the input phosphor vacuum tube was only slightly convex
in the 6 inch mode, which minimized pincushion distortion.
Flatness of field with this system was specified as ± 3%;
therefore, correction of field nonuniformity was unneces-
sary.
Coronary cine frames were selected for analysis based
on the following criteria: First, frames were selected from
the middle phase of the contrast injection, when the stenotic
lesion was well opacified. Second, selected frames had to
display the long axis of the arterial segment without fore-
shortening. Therefore, radiographic projections were chosen
in which the X-ray beam was approximately perpendicular
to the long axis of the artery. Third, frames had to display
the stenotic segment and an adjacent normal segment clearly.
with both segments located away from extreme margins of
the field.
The cine frame selected for analysis was projected with
a modified Vanguard projector into a Panasonic model WV-
1500 video camera. Light from the illuminated frame was
focused with approximately twofold magnification onto the
vidicon tube in the camera. The video camera was operated
with the automatic light compensation circuit off so that the
target voltage of the pickup tube was fixed rather than au-
tomatically adjusted.
Cinevideodensitometry. The RS-170 signal produced
by the vidicon camera was digitized by a video digitizer
interface and analyzed with a software system (A2.5 Med-
ical Data Systems) on a Nova 4 computer. This system
consists of a central processor with a 256 Kbyte mainframe
memory, 10 and 300 Mbyte disk drives, tape drives and a
separate pipeline processing rack with 2 Mbyte image mern-
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Figure 1. Cinevideodensitometric anal-
yses of digitized cine frames from coro-
nary arteriograms. A, From a study
showing a minor lesion(8% stenosis) in
the proximal leftcircumflex artery (hor-
izontal bars) . Regions of interest were
positioned over the narrowed and nor-
mal arterial segments, with smaller ad-
jacent regions for measurement of back-
ground density. Percent stenosis was
calculated from the resulting videoden-
sitometric values after correction for
background density. B, From a repeat
coronaryarteriogramin the same patient
20 months later. Quantitative analysis
shows that the degree of stenosis (88%)
of the circumflex artery lesion has pro-
gressed markedly.
Figure 2. Intraobserverreproducibility of cinevideodensitometric
measurement of coronary artery stenoses. One operator measured
the percent area reduction of the same 38 coronary artery stenoses
on two occasions 3 months apart. The correlation coefficient (r)
for these two sets of measurements was 0 .97.
shown to be high, a study of intraobserver reproducibility
was performed. The same operator performed repeat cine-
videodensitometric measurements of 38 lesions at a 3 month
interval. The correlation coefficient for these two sets of
measurements was r = 0.97 (Fig . 2).
10 080604020
Initial Cinevideodensitometric Measurement
of Coronary Stenosis (% Area Reduction)
10 0
ory , video acquisition logic and display control logic. Each
incoming video level was converted into an eight bit binary
value, representing one byte of converted video data.
The selected frame was then digitized in the static ac-
quisition mode to a 512 x 512 pixel matrix with 256 gray
scale levels and stored in the video analyzer memory. The
digitized image was analyzed quantitatively by positioning
rectangular regions of interest on the digitized image dis-
played on the monitor screen with a joystick. Using a semi-
automated algorithm, rectangular regions of interest, 2 pix-
els in width, were positioned across the stenotic and normal
segments of the artery (Fig. I). One region of interest was
centered over the narrowest site of the stenotic lesion, and
the other was positioned over the normal arterial segment
adjacent and proximal to the stenosis . Each region of interest
was long enough to extend beyond both margins of the
arterial lumen . Two small region s of interest (each 2 x 2
pixels) were positioned adjacent to the ends of each of the
other regions of interest for determining average background
videodensity. The background-corrected videodensitometric
value (Vc) acro ss the arterial segment was then calculated
as : Vc = V - nb, where V is the total videodensitometric
value in the region of interest acro ss the arterial segment ,
n is the number of pixels in the region of interest and b is
the average background density per pixel. Computations
were performed by a program developed by Medical Data
Systems .
In addition to previously reported validation studies (22)
of this technique, in which interobserver reproducibility was
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Results
Table 1. Clinical Characteristics of the 44 Subjects at the Time
of the First Coronary Arteriogram
Figure 3. Mean percent stenosis for each subject on the first and
second arteriograms. Mean percent stenosis for the entire group
(n = 44) was 64% on the first arteriogram and 76% on the second
arteriogram. Progression of stenosis was observed in 40 of the 44
subjects in the total study shown and in all subjects who had
worsening symptoms of ischemic heart disease.
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Coronary angiographic findings. The clinical charac-
teristics of the subjects are shown in Table I. At the time
of the first arteriogram. I patient had normal coronary ar-
teries. 3 patients had stenosis of one coronary major artery,
14 had stenoses of two major arteries and 26 had stenoses
of three or four major arteries. The mean interval between
arteriograms was 29.3 months (range 6 to 89). Overall pro-
gression of stenosis was observed in 40 of the 44 subjects
(Fig. 3).
There were 144 stenotic arterial segments suitable for
analysis (Table 2). Of these. 25 (17%) progressed by 75%
or more. 57 (40%) progressed by 50% or more and 87 (60%)
progressed by 25% or more. Progression to 100% occlusion
was observed in 10 arterial segments with less than 90%
stenosis at baseline, with these 10 segments being distrib-
uted among nine patients. Eleven arterial segments com-
Statistical analysis. To account for the variation in per-
cent stenosis among arterial segments on the first arterio-
gram. progression was defined as the change in percent
stenosis divided by the percent patent lumen (100 - percent
stenosis) at the first arteriogram. For example, a lesion that
progressed from 60 to 80% stenosis progressed by (80% -
60%)/40% = 50%. where 40% is the percent of patent
lumen at the first arteriogram. This procedure is necessary
to normalize the degree of progression across lesions, so
that all lesions have the potential for 100% progression
relative to their starting point and all measures of progression
are on the same scale. Because subjects had different num-
bers of analyzable lesions. ranging from one to nine. an
overall measure of progression for each subject was obtained
by calculating a weighted average of analyzable lesions.
with the weights equal to the percent of patent lumen at the
first arteriogram. For example. a subject with two analyzable
lesions. the first progressing from 20 to 40% stenosis (pro-
gression = (40% - 20%)/80% = 25%) and the second
progressing from 60 to 80% stenosis (progression = 50%)
would have overall progression calculated as [(0.25)(80) +
(0.50)(40)]1(120) = 0.33% Individual lesions with initial
stenosis exceeding 90% were excluded from analysis as
essentially total occlusions. Individual lesions that showed
progression of zero or less were set equal to zero. This
procedure was used because the amount of stenosis at risk
for regression. rather than the amount of lumen at risk for
progression. would have had to be used to normalize these
values. and this would have created a variable describing
progression with a discontinuity at zero.
Because of the strong relation between the interval be-
tween arteriograms and the extent of progression of stenosis.
all regression analyses of progression against risk factors
were adjusted for the duration of the interval between ar-
teriograms entered as a continuous variable. To obtain plots
of progression against clinical variables. progression was
first adjusted for duration of the interval between arterio-
grams by performing a simple regression of progression on
duration. The coefficient for the term for duration was then
entered as the coefficient (B) in the following equation: PA
P - B (0 - 30), where PA = adjusted progression.
P = mean normalized progression (as defined above),
o = actual duration in months of the interval between
arteriograms for an individual subject and 0 - 30 is the
individual departure from the group mean duration. Data
analysis was performed using the Statistical Analysis Sys-
tem (26). Associations between risk factors and progression
were examined in regression analyses using partial F tests.
In all regression analyses. weighted mean overall progres-
sion for all lesions in each subject was used as the unit of
independent observation.
This study was approved by the Institutional Review
Board of the College of Physicians and Surgeons of Co-
lumbia University.
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Table 2. Characteristics of 144 Stenotic Coronary Arterial
Segments at the Initial Coronary Arteriogram
Percent
Stenosis* RCA LM LAD LCx
o to 25 7 0 7 2
26 to 50 8 0 9 4
5 1 to 75 9 0 23 23
76 to 90 5 I 18 13
> 90 6 0 5 4
*Some subjects had several stenoses in one arterial segment. LAD =
left anterior descending coronary artery: LCx = left circumflex coronary
artery: LM = left main coronary artery; RCA = right coronary artery.
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Figure 4. Regression analysis of the relation between percent
progression of coronary artery stenosis and the duration of the
interval in months between arteriograms.
pletely free of stenosis at baseline progressed to 20% or
greater stenosis at the second arteriogram. These II seg-
ments were distributed among six patients. Regression of
10% or greater was observed in 16 arteries in 14 patients.
Determinants of progression. The degree of overall
progression of stenosis was strongly related to the time
interval between arteriograms (F = 5.81, P < 0.05 ) (Fig.
4), but even at short intervals measurable progression oc-
curred. The mean1rogression at 24 months was 39% (90%confidence interW¢33 to 45%) and at 36 months was 48%
(90% confidence interval, 40 to 56%).
Of all clinical variables considered. only serum choles-
terol level was significantly related to the degree of pro-
gression of stenosis. Figure 5 shows the relation between
the degree of progression (adjusted for duration of the in-
terval between arteriograms) and serum cholesterol level at
the time of the first arteriogram. This relation is statistically
significant (F = 4.37, P < 0.05) with a regression coefficient
of 0.11 , indicating that each increase of 10 mg/dl in serum
cholesterol was associated with an additional I% increase
in progression of stenosis over 29 months (mean time of
observation of the study group). The individual regressions
of all other coronary risk factors in Table I produced values
for the partial F test corresponding to a probability value
greater than 0.05 with the exception of age, which was
100
Discussion
These data indicate that progression of coronary athero-
sclerotic disease can be detected by computer-assisted
cinevideodensitometry in symptomatic patients with a mean
interval between arteriograms of 30 months. In these pa-
tients, serum cholesterol was the most powerful clinical
determinant of progression.
Advantages of cinevideodensitometry. Our study dif-
fers from previous arteriographic studies of progression of
coronary artery disease (5- 14) in using a quantitative.
cinevideodensitometric method to measure percent stenosis
by analysis of coronary arteriograms. The increased accu-
racy of cinevideodensitometry in comparison with visual or
caliper methods of estimating stenosis is based on several
features. First, the computer quantifies regional film density
with a gray scale of 256 levels, whereas the human eye can
differentiate only approximately 20 gray scale levels (27).
Furthermore , digitization of each cine frame into a 512 x
5 12 pixel format yields a pixel density of 60 to 70 pix-
Figure S. Regression analysis of the relation between percent
progression of coronary artery disease and serum cholesterol level
at the time of thefirst arteriogram. Progression of disease has been
adjusted for duration of the interval between arteriograms to ac-
count for the relation between duration and progression.
inversely associated with progression of stenosis (p = 0.03).
Multivariate analysis of serum cholesterol and age together,
however, yielded a nonsignificant partial F test for age when
serum cholesterol was entered first (p = 0.10). Age was
inversely correlated with serum cholesterol in our study
group because of the presence of several younger patients
with severe hypercholesterolemia.
Because all subjects underwent the second coronary ar-
teriogram to evaluate progression of symptoms, confirma-
tory analysis was done excluding in each subject the single
stenosis that progressed by the greatest amount. However,
the findings were not altered by this analysis.
x'
{3= 0.00 37
F = 5.8 1
P < 0 .05
x x
x
CJ)
~ ~
z z
o w 80~:;;
~ ~ 60
(!)w
o l-
g: ~ 40
l- ~
Z '"~ ~ 20
'" 0
w '"Q. 0
(J
1330 SHEA ET AL.
PROGRESSION OF CORONARY DISEASE
JACe Vol. ~. No, 6
December 1986: 1325-3I
els/mrrr', so that regional film density is quantified in minute
detail. Previous radiographic experiments (22) have shown
that this method is highly accurate in measuring the volume
of contrast material within the arterial lumen.
Second, cinevideodensitometric analysis is advantageous
because precise identification of arterial borders is unnec-
essary. With caliper methods or techniques involving man-
ual tracing of projected coronary arteriograms or computer-
assisted edge detection algorithms (5), identification of
arterial borders is required . However, radiographic absorp-
tion unsharpness caused by the gradual change in X-ray
absorption across the edge of a cylindrical column of con-
trast medium may result in poorly defined margins on the
arteriographic film (28) and limit the accuracy of edge de-
tection methods. Cinevideodensitometry, on the other hand,
compares the total videodensity of contrast material in the
stenotic arterial segment with the videodensity in the normal
arterial segment without the need for edge detection . After
subtraction of average background density per pixel from
the video value for each pixel across the arterial lumen, the
videodensity values are summed, and the total videodensity
value reflects the amount of contrast material in the arterial
lumen. Since the videodensity values are larger in the central
region of the arterial lumen and smaller toward the borders,
the boundary regions contribute relatively little to the mea-
surement.
Third. cinevideodensitometric analysis is suitable for
measurement of eccentric stenotic lesions . because the total
videodensity of contrast medium within the arterial lumen
does not change in different radiographic projections (22) .
Caliper measurements or methods requiring detection of the
borders of projected coronary arteriograms may be limited
because stenotic lesions are frequently eccentric (29) and
must be measured in multiple angiographic projections to
correct for eccentricity.
Cinevideodensitometric analysis is less subjective and
reduces interobserver variation . In addition, the increased
accuracy of cinevideodensitometry permits analysis of pro-
gression as a continuous variable (percent progression) rather
than as a categorical variable (progression versus no pro-
gression) . All of these considerations may contribute to the
detection in our study of a small number of patients over a
relatively short time interval of a clinically and statistically
significant relation between serum cholesterol and progres-
sion of coronary atherosclerotic disease .
Limitations of the study. Our study group is not rep-
resentative of the population as a ' whole, or even of the
subpopulation with symptomatic coronary heart disease . Only
one patient had normal coronary arteries at the time of the
first arteriogram (Fig. 3) and all patients had worsening
symptoms before the second arteriogram, so little can be
concluded from this study about the course of coronary
atherosclerosis in less severely ill patients. Despite these
limiting characteristics, our study provides information about
the course of coronary artery disease in an important subset
of patients . There is no reason to believe that these limi-
tations in patient selection affected the positive association
of serum cholesterol with progression of stenosis .
Another possible limitation of the study may be the sta-
tistical model used to define progression of stenosis. Pro-
gression was defined as the change in percent stenosis be-
tween arteriograms divided by the percent of lumen patent
at the first arteriogram , which expresses the percent of lumen
at risk for further stenosis . By this method , a stenosis in-
creasing from 80 to 90% would progress by the same amount
(50%) as a lesion increasing from 20 to 60%. This model
was chosen so that all lesions at the time of the first arte-
riogram had a range of potential progression from zero to
100%. Other investigators (13,14,30) have also measured
progression in terms of change in percent stenosis, but some
(5) have measured progression in terms of change in absolute
dimension of patent lumen. No single approach to defining
progression in clinical and epidemiologic studies has been
generally accepted.
The lack ofan association in our data between progres-
sion of stenosis and other coronary risk factors . such as
smoking or blood pressure, may be due to a true lack of
any significant relation or to a lack of statistical power. Only
seven patients (17%) were smokers and five (12%) were
diabetic . Many patients with hypertension were treated with
diuretic agents, nitrates and beta-adrenergic blocking agents,
so that the range of blood pressure was reduced . Power
calculations based on the observed differences in degree of
progression between smokers and nonsmokers and between
diabetic and nondiabetic patients , and using alpha = 0.05
and one tail of the standard normal distribution, show power
of only 5% for smoking and 43% for diabetic patients. It
is less likely that the lack of association was due to con-
founding, because all risk factors were tested in multivariate
models including serum cholesterol , as well as by univariate
analysis, and no associations were found. Consistent with
these negative findings, the Framingham multivariate risk
function was not significantly associated with progression
of stenosis. This may be due to the presence in our study
of several young subjects with severely elevated serum cho-
lesterol levels. Because of the presence of these subjects ,
serum cholesterol was inversely related to age in our data,
and this relation explained the inverse association between
age and progression in univariate but not in multivariate
analysis.
Clinical implications. The finding that serum choles-
terol level is an important determinant of progression of
stenosis over a time interval as short as 30 months strength-
ens the hypothesis that serum cholesterol reduction by diet
or other means may have important secondary prevention
benefits in symptomatic patients . Such a benefit would be
consistent with the benefit found in the Lipid Research Clin-
ics Trial (31) for serum cholesterol reduction as a means of
primary prevention in asymptomatic subjects. In that trial,
angiographic data suggested that reduction in progression
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of coronary artery stenosis was the mechanism by which
the benefit of lowered serum cholesterol was conferred
(13,14). Another recent study (5) found a relation between
diet, several intervening coronary risk factors (including
total serum cholesterol) and progression of coronary ath-
erosclerosis. In addition, arteriographic studies of progres-
sion of femoral atherosclerosis have found serum cholesterol
to be related to progression (32,33). The ability of cinevi-
deodensitometric analysis of coronary arteriograms to mea-
sure progression of stenosis at a mean interval between
arteriograms of 30 months suggests that this technique may
be useful in clinical trials of interventions designed to slow
or reverse progression of coronary atherosclerosis.
Conclusions. We used a validated quantitative method,
cinevideodensitometry, to measure progression of coronary
artery atherosclerosis. In a selected population with wors-
ening symptoms, we found substantial progression of ste-
nosis within 2 to 3 years, Progression was associated with
the serum cholesterol level but not with other coronary risk
factors. Our data are consistent with the concept that the
serum cholesterol level is an important determinant of pro-
gression of coronary atherosclerosis in symptomatic pa-
tients.
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